Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 9, 2023Frontiers in BacteriologyOpen Access

Artificial intelligence in accelerating vaccine development - current and future perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

RKRahul KaushikRKRavi KantMCMyron Christodoulides

Discussion

Loading...

Member takes

Overview

Narrative review demonstrates computational artificial intelligence methods for identifying bacterial vaccine candidates, highlighting novel pipelines to counter antimicrobial resistance.

Key Points

  • To review computational and artificial intelligence-assisted methodologies that accelerate vaccine candidate discovery against multi-drug resistant bacterial pathogens.
  • Synthesized literature on computational pipelines that replace conventional empirical discovery workflows.
  • Evaluated artificial intelligence algorithms used to screen and identify antigenic targets in multi-drug resistant bacteria.
  • Identified computational approaches as effective alternatives that compress the timeline of traditional vaccine discovery.
  • Highlighted algorithmic screening strategies that successfully detect viable vaccine candidates against resistant bacterial targets.

Cite This Study

Kaushik et al. (2023) studied this question.

synapsesocial.com/papers/69dbe01a387cf70698689172https://doi.org/10.3389/fbrio.2023.1258159
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression2022 · 1,236 citations
  2. 2VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines2007 · 3,093 citations
  3. 3Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study2019 · 42 citations